Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Attempts to Induce t(11;14) during Redifferentiation of Normal B Cell-Derived Ips Cells to Study Myeloma-Initiating Cells

Naohiro Tsuyama, Misaki Takahashi Sugai, Ken-ichi Kudo, Yusuke Azami, Megumi Sasatani, Kenji Kamiya, Takayuki Ikezoe, Masafumi Onodera, Akira Sakai

Blood (2022) 140 (Supplement 1): 12471–12472.

https://doi.org/10.1182/blood-2022-158655

Published: 2022

Journal Articles

Normal B Cell-Derived iPSCs Capable of Inducing RAS Mutants and Aid to Explore Myeloma-Initiating Cells

Ken-ichi Kudo, Naohiro Tsuyama, Misaki Takahashi Sugai, Yusuke Azami, Miwa Fukami, Yu Abe, Akinobu Ota, Karnan Sivasundaram, Moe Muramatsu, Megumi Sasatani, Yuko Hashimoto, Shigehira Saji, Kenji Kamiya, Ichiro Hanamura, Takayuki Ikezoe, Masafumi Onodera, Akira Sakai

Blood (2021) 138 (Supplement 1): 4711.

https://doi.org/10.1182/blood-2021-149108

Published: 2021

Journal Articles

Chromosomal Translocation t(11;14) Induced By the Cre-Loxp System in Normal B Cell-Derived Ips Cells for the Study of Myeloma-Initiating Cells

Misaki Sugai, BS, Naohiro Tsuyama, PhD, Yu Abe, PhD, Yusuke Azami, MD, Kenichi Kudo, PhD, Akinobu Ota, PhD, Sivasundaram Karnan, PhD, Moe Muramatsu, BS, Tomonari Shigemura, MD PhD, Megumi Sasatani, PhD, Yuko Hashimoto, MD PhD, Kenji Kamiya, MD PhD, Ichiro Hanamura, MD PhD, Takayuki Ikezoe, MD PhD, Masafumi Onodera, MD PhD, Akira Sakai, MD PhD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-134572

Published: 2020

Journal Articles

Introduction of Chromosomal Translocation t(11; 14) and a p53 Deletion into Normal B Cell-Derived iPSCs to Elucidate the Cellular Origin of Myeloma Cells

Aki Yanagi, MS, Naohiro Tsuyama, PhD, Misaki Sugai, BS, Yu Abe, PhD, Yusuke Azami, MD, Yukari Yanai, MS, Akinobu Ota, PhD, Karnan Sivasundaram, PhD, Moe Muramatsu, BS, Tomonari Shigemura, MD PhD, Megumi Sasatani, PhD, Yuko Hashimoto, MD PhD, Kenji Kamiya, MD PhD, Ichiro Hanamura, MD PhD, Takayuki Ikezoe, MD PhD, Masafumi Onodera, MD PhD, Akira Sakai, MD PhD

Blood (2019) 134 (Supplement_1): 3057.

https://doi.org/10.1182/blood-2019-122344

Published: 2019

Journal Articles

Attempt to Prove the Existence of Abnormal B Lymphocyte As Myeloma-Initiating Cells from B Cell-Derived Induced Pluripotent Stem Cells

Aki Yanagi, MS, Naohiro Tsuyama, PhD, Yukari Yanai, MS, Yu Abe, PhD, Misaki Sugai, BS, Akinobu Ota, PhD, Karnan Sivasundaram, PhD, Tomonari Shigemura, MD PhD, Megumi Sasatani, PhD, Kenji Kamiya, MD PhD, Ichiro Hanamura, MD PhD, Takayuki Ikezoe, MD PhD, Masafumi Onodera, MD PhD, Akira Sakai, MD PhD

Blood (2018) 132 (Supplement 1): 1896.

https://doi.org/10.1182/blood-2018-99-112759

Published: 2018

Journal Articles

B Cell-Derived Induced Pluripotent Stem Cells Are Useful for Determining the Cellular Origin of Abnormal B Cells in Multiple Myeloma

Aki Yanagi, Fumihiko Kawamura, MS, Makoto Inaki, PhD, Atsushi Katafuchi, PhD, Yukari Yanai, MS, Yu Abe, MD, Naohiro Tsuyama, PhD, Misaki Sugai, BS, Mitsunori Higuchi, MD PhD, Satoshi Muto, MD PhD, Takumi Yamaura, MD, Hiroyuki Suzuki, MD PhD, Hideyoshi Noji, MD PhD, Shinichi Suzuki, MD PhD, Yoshida A Mitsuaki, PhD, Megumi Sasatani, PhD, Kenji Kamiya, MD PhD, Masafumi Onodera, MD PhD, Akira Sakai, MDPhD

Blood (2017) 130 (Supplement 1): 1808.

https://doi.org/10.1182/blood.V130.Suppl_1.1808.1808

Published: 2017

Journal Articles

Establishment of Induced Pluripotent Stem Cells from Lymph Node B Cells and Induction of Aid Expression in Their Differentiation into Hematopoietic Stem Cells

Fumihiko Kawamura, MS, Inaki Makoto, PhD, Atsushi Katafuchi, PhD, Yu Abe, MS, Naohiro Tsuyama, PhD, Yumiko Kurosu, BS, Aki Yanagi, MS, Mitsunori Higuchi, MD PhD, Satoshi Muto, MD PhD, Takumi Yamamura, MD, Hiroyuki Suzuki, MD PhD, Hideyoshi Noji, MD PhD, Shinichi Suzuki, MD PhD, Mitsuaki A Yoshida, PhD, Megumi Sasatani, PhD, Kenji Kamiya, MD PhD, Masafumi Onodera, MD PhD, Akira Sakai, MD PhD

Blood (2016) 128 (22): 5049.

https://doi.org/10.1182/blood.V128.22.5049.5049

Published: 2016

Journal Articles

Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan

Blood (2012) 119 (12): 2837–2843.

https://doi.org/10.1182/blood-2011-08-374371

Published: 2012

Journal Articles

Decreased CD138 Expression in Myeloma Cells: A Potential Indicator of Poor Prognosis and Aberrant Differentiation,

Yawara Kawano, MD, Shiho Fujiwara, MD, Hiromichi Yuki, MD, Hiro Tatetsu, MD, PhD, Hiroshi Yamasaki, MD, PhD, Akira Sakai, MD, PhD, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, MD, PhD, Hiroyuki Hata, MD, PhD

Blood (2011) 118 (21): 3939.

https://doi.org/10.1182/blood.V118.21.3939.3939

Published: 2011

Journal Articles

T-Cell Immunotherapy with a Chimeric Receptor Against CD38 Is Effective in Eliminating Myeloma Cells

Keichiro Mihara, MD, PhD, Joyeeta Bhattacharyya, MD, PhD, Akira Kitanaka, MD, PhD, Akihiro Ihara, MD, PhD, Akira Sakai, MD, PhD, Yoshiaki Kuroda, MD, PhD, Hideki Asaoku, MD, Yoshihiro Takihara, MD, PhD, Akiro Kimura, MD

Blood (2011) 118 (21): 885.

https://doi.org/10.1182/blood.V118.21.885.885

Published: 2011

Journal Articles

The Role of Activation-Induced Cytidine Deaminase (AID/AICDA) in the Progression of Follicular Lymphoma

Hisaharu Shikata, Yoshihiro Yakushijin, MD, PhD, Natsuki Matsushita, Akira Sakai, MD, PhD, Atsuro Sugita, Naoya Nakamura, MD, PhD, Jun Yamanouchi, MD, PhD, Taichi Azuma, Takaaki Hato, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2011) 118 (21): 5234.

https://doi.org/10.1182/blood.V118.21.5234.5234

Published: 2011

Journal Articles

A Phase I/II Study of Bortezomib in Combination with Melphalan and Prednisolone in Japanese Patients with Newly Diagnosed Multiple Myeloma

Kenshi Suzuki, MD, PhD, Kiyoshi Ando, MD, PhD, Akira Sakai, MD, PhD, Shinsuke Iida, MD, PhD, Michinori Ogura, Kensei Tobinai, MD, PhD, Morio Matsumoto, MD, Kosei Matsue, MD, PhD, Yasuhito Terui, MD, PhD, Kazuteru Ohashi, MD, Takaaki Chou, MD, PhD, Kazutaka Sunami, MD, PhD, Atsushi Shinagawa, MD, Nobuyuki Aotsuka, MD, PhD, Hirohiko Shibayama, MD, PhD, Takayuki Takahashi, MD, PhD, Harumi Yamamoto Mukai, MD, PhD, Tomomitsu Hotta, MD, PhD

Blood (2011) 118 (21): 5132.

https://doi.org/10.1182/blood.V118.21.5132.5132

Published: 2011

Journal Articles

Hepatic toxicity and prognosis in hepatitis C virus–infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis

Blood (2010) 116 (24): 5119–5125.

https://doi.org/10.1182/blood-2010-06-289231

Published: 2010

Includes: Supplemental data

Journal Articles

A Retrospective Analysis on Prognostic Factors of Angioimmunoblastic T-Cell Lymphoma: a Multicenter Cooperative Study In Japan

Blood (2010) 116 (21): 3117.

https://doi.org/10.1182/blood.V116.21.3117.3117

Published: 2010

Journal Articles

Establishment of An HS23 Stromal Cell-Dependent Myeloma Cell Line: Fibronectin and IL-6 Are Critical for Survival

Akira Sakai, MD, PhD, Miyo Oda, PhD, Noriaki Yoshida, MD, Mitsuhiro Itagaki, MD, Koji Arihiro, MD, PhD, Akiro Kimura, MD, PhD

Blood (2010) 116 (21): 2949.

https://doi.org/10.1182/blood.V116.21.2949.2949

Published: 2010

Journal Articles

The Impact of Outcome and Hepatic Toxicity in HCV-Infected Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab Plus CHOP Therapy; A Retrospective Multicenter Japanese Analysis.

Blood (2009) 114 (22): 2700.

https://doi.org/10.1182/blood.V114.22.2700.2700

Published: 2009

Journal Articles

Levels of sIL-2R in Sera Depend On Number of CD25-Positive Lymphoma Cells and MMP-9-Positive Macrophages in DLBCL.

Noriaki Yoshida, MD, Akira Sakai, MD, PhD, Yoshiko Okikawa, MD, Yuta Katayama, MD, PhD, Hideki Asaoku, MD, Hirotaka Matsui, MD, PhD, Koji Arihiro, MD, PhD, Megumu Fujihara, MD, PhD, Takashi Nishisaka, MD, PhD, Naomi Sasaki, MD, PhD, Yoshito Sadahira, MD, PhD, Akiro Kimura, MD, PhD

Blood (2009) 114 (22): 2927.

https://doi.org/10.1182/blood.V114.22.2927.2927

Published: 2009

Journal Articles

Significance of Serum Soluble IL-2R in DLBCL and FL Is Different from That in ATL

Noriaki Yoshida, MD, Akira Sakai, MD, PhD, Yoshiko Okikawa, MD, Hideaki Nitta, MD, Takashi Nishisaka, MD, PhD, Akiro Kimura, MD, PhD

Blood (2008) 112 (11): 2817.

https://doi.org/10.1182/blood.V112.11.2817.2817

Published: 2008

Journal Articles

Clinical Significance of CD21 Co-Expressed with LFA-1 in Non-Hodgkin’s B-Cell Lymphoma.

Kazushi Tanimoto, MD, Yoshihiro Yakushijin, MD, PhD, Hiroshi Fujiwara, MD, PhD, Masaki Otsuka, MD, PhD, Koichi Ohshima, MD, PhD, Atsuro Sugita, MD, PhD, Akira Sakai, MD, PhD, Takaaki Hato, MD, PhD, Hitoshi Hasegawa, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2008) 112 (11): 1781.

https://doi.org/10.1182/blood.V112.11.1781.1781

Published: 2008

Journal Articles

Cyclin D1 Overexpression Increases Chemosensitivity Via Prolonged S-Phase and TRAIL Signal in Myeloma Cell.

Yoshiaki Kuroda, MD, Akira Sakai, M.D., Naohiro Tsuyama, Ph.D., Yuta Katayama, M.D., Shoso Munemasa, M.D., Yoshiko Okikawa, M.D., Hideki Asaoku, M.D., Nanae Nakaju, Mami Mizuno, Takashi Nishizaka, M.D., Katsunari Ogawa, Hideo Tanaka, M.D., Akiro Kimura, M.D.

Blood (2007) 110 (11): 3530.

https://doi.org/10.1182/blood.V110.11.3530.3530

Published: 2007

NARROW

Attempts to Induce t(11;14) during Redifferentiation of Normal B Cell-Derived Ips Cells to Study Myeloma-Initiating Cells

Normal B Cell-Derived iPSCs Capable of Inducing RAS Mutants and Aid to Explore Myeloma-Initiating Cells

Chromosomal Translocation t(11;14) Induced By the Cre-Loxp System in Normal B Cell-Derived Ips Cells for the Study of Myeloma-Initiating Cells

Introduction of Chromosomal Translocation t(11; 14) and a p53 Deletion into Normal B Cell-Derived iPSCs to Elucidate the Cellular Origin of Myeloma Cells

Attempt to Prove the Existence of Abnormal B Lymphocyte As Myeloma-Initiating Cells from B Cell-Derived Induced Pluripotent Stem Cells

B Cell-Derived Induced Pluripotent Stem Cells Are Useful for Determining the Cellular Origin of Abnormal B Cells in Multiple Myeloma

Establishment of Induced Pluripotent Stem Cells from Lymph Node B Cells and Induction of Aid Expression in Their Differentiation into Hematopoietic Stem Cells

Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan

Decreased CD138 Expression in Myeloma Cells: A Potential Indicator of Poor Prognosis and Aberrant Differentiation,

T-Cell Immunotherapy with a Chimeric Receptor Against CD38 Is Effective in Eliminating Myeloma Cells

The Role of Activation-Induced Cytidine Deaminase (AID/AICDA) in the Progression of Follicular Lymphoma

A Phase I/II Study of Bortezomib in Combination with Melphalan and Prednisolone in Japanese Patients with Newly Diagnosed Multiple Myeloma

Hepatic toxicity and prognosis in hepatitis C virus–infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis

A Retrospective Analysis on Prognostic Factors of Angioimmunoblastic T-Cell Lymphoma: a Multicenter Cooperative Study In Japan

Establishment of An HS23 Stromal Cell-Dependent Myeloma Cell Line: Fibronectin and IL-6 Are Critical for Survival

The Impact of Outcome and Hepatic Toxicity in HCV-Infected Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab Plus CHOP Therapy; A Retrospective Multicenter Japanese Analysis.

Levels of sIL-2R in Sera Depend On Number of CD25-Positive Lymphoma Cells and MMP-9-Positive Macrophages in DLBCL.

Significance of Serum Soluble IL-2R in DLBCL and FL Is Different from That in ATL

Clinical Significance of CD21 Co-Expressed with LFA-1 in Non-Hodgkin’s B-Cell Lymphoma.

Cyclin D1 Overexpression Increases Chemosensitivity Via Prolonged S-Phase and TRAIL Signal in Myeloma Cell.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only